Buscar
ICU Medical Inc
ICUIAñadir a la lista de seguimiento
165.610USD
+4.150+2.57%
Cierre 07-28 16:00（ET）Cotizaciones retrasadas 15 min
4.14BCap. mercado
88.22P/E TTM
Más Datos de ICU Medical Inc Compañía
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
Información de ICU Medical Inc
Símbolo de cotizaciónICUI
Nombre de la empresaICU Medical Inc
Fecha de salida a bolsaMar 31, 1992
Director ejecutivoJain (Vivek)
Número de empleados15000
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 31
Dirección951 Calle Amanecer
CiudadSAN CLEMENTE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92673-6212
Teléfono19493662183
Sitio Webhttps://www.icumed.com/
Símbolo de cotizaciónICUI
Fecha de salida a bolsaMar 31, 1992
Director ejecutivoJain (Vivek)
Ejecutivos de ICU Medical Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Vivek Jain
Mr. Vivek Jain
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
279.17K
+44.40%
Mr. Brian Michael Bonnell
Mr. Brian Michael Bonnell
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
71.75K
+57.70%
Mr. Christian B. Voigtlander
Mr. Christian B. Voigtlander
Chief Operating Officer
Chief Operating Officer
46.31K
+86.85%
Mr. Daniel (Dan) Woolson
Mr. Daniel (Dan) Woolson
President
President
22.48K
-9.44%
Mr. David C. Greenberg, J.D.
Mr. David C. Greenberg, J.D.
Lead Independent Director
Lead Independent Director
9.71K
+12.91%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
6.00K
+20.89%
Ms. Laurie Hernandez
Ms. Laurie Hernandez
Independent Director
Independent Director
4.86K
+25.79%
Ms. Kolleen T. Kennedy
Ms. Kolleen T. Kennedy
Independent Director
Independent Director
4.54K
+27.63%
Ms. Elisha W. Finney
Ms. Elisha W. Finney
Independent Director
Independent Director
4.51K
+27.83%
Mr. John Mills
Mr. John Mills
Investor Relations
Investor Relations
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Vivek Jain
Mr. Vivek Jain
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
279.17K
+44.40%
Mr. Brian Michael Bonnell
Mr. Brian Michael Bonnell
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
71.75K
+57.70%
Mr. Christian B. Voigtlander
Mr. Christian B. Voigtlander
Chief Operating Officer
Chief Operating Officer
46.31K
+86.85%
Mr. Daniel (Dan) Woolson
Mr. Daniel (Dan) Woolson
President
President
22.48K
-9.44%
Mr. David C. Greenberg, J.D.
Mr. David C. Greenberg, J.D.
Lead Independent Director
Lead Independent Director
9.71K
+12.91%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
6.00K
+20.89%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de ICU Medical Inc?
Los cinco principales accionistas de ICU Medical Inc son: Mr. Vivek Jain
¿Cuántas instituciones poseen acciones de ICU Medical Inc (ICUI)?
A fecha de 2026Q1, 628 instituciones poseen acciones de ICU Medical Inc, con un valor de mercado combinado de aproximadamente 28.59M, lo que representa el 114.41% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 638369.00.
¿Cuál es la mayor fuente de ganancias de ICU Medical Inc?
El 2026Q1, el segmento empresarial Infusion Consumables generó la ganancia más alta para ICU Medical Inc, ascendiendo a 1.11B y representando el 49.71% de la ganancia total.